Treating maculopathy at the expense of proliferative disease: an emerging problem in 'macular treatment centres'. [electronic resource]
Producer: 20150521Description: 1390-1 p. digitalISSN:- 1476-5454
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Diabetes Mellitus, Type 1 -- complications
- Diabetic Retinopathy -- drug therapy
- Humans
- Intravitreal Injections
- Laser Coagulation
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Postoperative Complications
- Ranibizumab
- Retinal Neovascularization -- diagnosis
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.